Virinchi Ltd. (VIRINCHI) AI Stock Analysis

• Market Cap: ₹2.88B
• Dividend Yield: N/A
• Average Volume (3M): 49.69K
• Price to Earnings (P/E): 4841.4
• Beta (1Y): 0.82
• Revenue Growth: -1.40%
• EPS Growth: -238.47%
• Country: IN
• Employees: 1,033
• Sector: Healthcare
• Sector Strength: 45
• Industry: Software - Application
• EPS (TTM): -1.32
• Shares Outstanding: 102,646,900
• 10 Day Avg. Volume: 10,427
• 30 Day Avg. Volume: 49,685
• PEG Ratio: -3.21
• Price to Book (P/B): 0.47
• Price to Sales (P/S): 0.74
• P/FCF Ratio: -8.73
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Hold
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 49 Neutral
• Price Target: ₹24.00 ▲(6.34% Upside)

Virinchi Ltd.'s stock score is primarily impacted by its weak financial performance and poor valuation metrics. The technical analysis indicates bearish momentum, further contributing to the low score. The absence of earnings call data and corporate events means these factors did not influence the score.

Positive Factors

Stable Balance Sheet

A stable balance sheet with a strong equity base and reasonable debt levels provides financial stability and supports long-term growth.

Healthcare Technology Offerings

Partnerships in healthcare technology enhance market position and revenue potential, leveraging industry growth trends in digital health.

Diverse Revenue Streams

Diverse revenue streams reduce reliance on a single market, enhancing resilience and providing multiple growth avenues.

Negative Factors

Declining Net Profit Margin

A declining net profit margin indicates reduced profitability, which can impact reinvestment capacity and shareholder returns.

Negative Free Cash Flow

Negative free cash flow suggests challenges in funding growth initiatives and maintaining financial flexibility without external financing.

Operational Inefficiencies

Operational inefficiencies can hinder competitive positioning and long-term profitability, requiring strategic improvements.

Virinchi Ltd. Business Overview & Revenue Model

Company Description

Virinchi Ltd. (VIRINCHI) is a technology-driven company based in India, primarily engaged in the fields of information technology and software services. The company offers a wide range of solutions, including enterprise resource planning (ERP), business process outsourcing (BPO), and software development services. Virinchi also operates in the healthcare sector, providing solutions that enhance operational efficiency for hospitals and healthcare providers. Its core products focus on improving business processes and delivering innovative technology solutions to its clients.

How the Company Makes Money

Virinchi generates revenue through multiple streams including software licensing, consulting services, and maintenance contracts associated with its ERP and IT solutions. The company also earns income from its BPO services by providing outsourced business services to various industries. Additionally, Virinchi capitalizes on its healthcare technology offerings by partnering with hospitals and healthcare organizations, which can include revenue-sharing agreements or ongoing service contracts. The company's strategic alliances with other tech firms and engagement in government projects further contribute to its revenue by expanding its market reach and enhancing service offerings.

Virinchi Ltd. Financial Statement Overview

Summary

Virinchi Ltd. faces challenges in profitability and cash flow, with a stable balance sheet. Revenue growth is slight, but net profit margin and cash flow have declined, indicating operational inefficiencies.

Income Statement

Virinchi Ltd. has shown a challenging revenue performance with a slight increase from 2024 to 2025. The Gross Profit Margin is stable, but Net Profit Margin has seen a sharp decline due to a significant drop in net income. The EBIT and EBITDA margins have also decreased, indicating pressure on operational efficiency.

Balance Sheet

The company maintains a strong equity base with a reasonable Debt-to-Equity Ratio. However, the Return on Equity has decreased significantly, reflecting reduced profitability. The Equity Ratio remains stable, supporting asset-backed equity financing.

Cash Flow

Cash flow from operations remains positive but has decreased from previous years. Free Cash Flow has turned negative, indicating potential issues in covering capital expenditures. The Operating Cash Flow to Net Income Ratio suggests some inefficiencies in converting earnings into cash.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	3.05B	3.01B	3.00B	3.12B	3.64B	3.54B
Gross Profit	1.69B	1.35B	1.79B	1.93B	3.36B	3.31B
EBITDA	1.00B	963.86M	1.14B	1.11B	1.04B	1.02B
Net Income	487.00K	7.24M	137.03M	128.49M	143.05M	27.46M
Balance Sheet
Total Assets	0.00	8.47B	8.51B	7.87B	7.03B	6.87B
Cash, Cash Equivalents and Short-Term Investments	77.58M	77.58M	200.25M	307.08M	366.00M	190.21M
Total Debt	0.00	2.92B	3.30B	3.17B	2.76B	2.61B
Total Liabilities	-4.74B	3.73B	3.97B	3.80B	3.33B	3.12B
Stockholders Equity	4.74B	4.76B	4.55B	4.08B	3.71B	3.76B
Cash Flow
Free Cash Flow	0.00	-253.64M	26.54M	-377.22M	525.18M	-1.04B
Operating Cash Flow	0.00	536.65M	1.16B	987.00M	846.73M	498.55M
Investing Cash Flow	0.00	-778.34M	-1.15B	-1.37B	-336.79M	-1.54B
Financing Cash Flow	0.00	119.01M	-127.06M	323.82M	-334.14M	1.15B

Virinchi Ltd. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 22.57
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Positive
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:VIRINCHI, the sentiment is Negative. The current price of 22.57 is below the 20-day moving average (MA) of 25.26, below the 50-day MA of 26.90, and below the 200-day MA of 25.41, indicating a bearish trend. The MACD of -1.24 indicates Positive momentum. The RSI at 22.84 is Positive, neither overbought nor oversold. The STOCH value of 14.14 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:VIRINCHI.

Virinchi Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
ALPA	70 Neutral	₹1.64B	8.77	―	―	14.53%	-10.49%
BAFNAPH	65 Neutral	₹3.61B	41.10	―	―	-0.77%	2055.99%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
VIRINCHI	49 Neutral	₹2.88B	4,841.38	―	―	-1.40%	-238.47%
AAREYDRUGS	46 Neutral	₹2.78B	66.68	―	―	-17.47%	-50.07%
KREBSBIO	41 Neutral	₹1.38B	-5.02	―	―	-46.31%	-26.28%

Virinchi Ltd. Corporate Events

Virinchi Limited Convenes EGM with Full Compliance

Virinchi Limited held its Extraordinary General Meeting (EGM) on November 15, 2025, via video conferencing, in line with regulatory requirements from the Ministry of Corporate Affairs and SEBI. The meeting was attended by 59 public members and several directors, including independent and non-executive directors, as well as the company’s whole-time directors and CFO. The proceedings were conducted in compliance with applicable provisions, ensuring transparency and adherence to corporate governance norms.